Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Share Capital (Details) - Schedule of options granted outstanding and exercise prices

v3.23.1
Share Capital (Details) - Schedule of options granted outstanding and exercise prices - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Schedule of Options Granted Outstanding and Exercise Prices [Abstract]    
Number of options, Outstanding at beginning 18,323,222 16,319,786
Weighted average exercise price, Outstanding at beginning $ 0.12 $ 0.12
Number of options, Outstanding at ending 22,267,758 18,323,222
Weighted average exercise price, Outstanding at ending $ 0.11 $ 0.12
Weighted average remaining contractual life (years), Outstanding at ending 4 years 7 months 28 days 4 years 11 months 19 days
Aggregate intrinsic-value, Outstanding at ending $ 342,452
Number of options, Exercisable 15,999,078 11,332,153
Weighted average exercise price, Exercisable $ 0.12 $ 0.08
Weighted average remaining contractual life (years), Exercisable 4 years 4 years 8 months 4 days
Aggregate intrinsic-value, Exercisable $ 233,086
Number of options, Granted 6,600,000 2,003,436
Weighted average exercise price, Granted $ 0.07 $ 0.17
Number of options, Options forfeited (2,655,464)  
Weighted average exercise price, Options forfeited $ 0.1